Medivir Ab Quote - 0GP7

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

41.70

Bid

0.00

Ask

0.00

Volume

0.00

0.00 Day's Range 0.00

41.70 52 Week Range 41.70

Market Cap

4.394B

Previous Close

41.70

Open

Last Trade

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

503

Shares Outstanding

105,371,000

Dividend Yield

PE Ratio

-49.19

Earnings Per Share (EPS)

-0.85

Revenue

7.66M

Net Profit

-89.32M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Diversified

Website

www.medivir.se

Headquarters

Huddinge, Swe

Founded

1992

Medivir Ab is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0GP7. The last closing price for Medivir Ab was SEK41.70. Over the last year, Medivir Ab shares have traded in a share price range of SEK 41.70 to SEK 41.70.

Medivir Ab currently has 105,371,000 shares outstanding. The market capitalization of Medivir Ab is SEK4.39 billion. Medivir Ab has a price to earnings ratio (PE ratio) of -49.19.

Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox

Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox PR Newswire STOCKHOLM, Jan. 15, 2024 STOCKHOLM, Jan. 15, 2024...

Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study

Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study PR Newswire STOCKHOLM, Jan. 4, 2024 STOCKHOLM, Jan. 4, 2024...

Fostrox + Lenvima demonstrates further improvement in durable clinical benefit in HCC, supporting the accelerated development plan

Fostrox + Lenvima demonstrates further improvement in durable clinical benefit in HCC, supporting the accelerated development plan PR Newswire STOCKHOLM, Dec. 19, 2023 Sustained disease control...

Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval

Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval PR Newswire STOCKHOLM, Dec. 13, 2023 STOCKHOLM...

Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway

Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway PR Newswire STOCKHOLM, Dec. 6, 2023 STOCKHOLM, Dec. 6, 2023 /PRNewswire/ -- Medivir AB...

Medivir to present at the Carlsquare Equity Research Investor Day

Medivir to present at the Carlsquare Equity Research Investor Day PR Newswire STOCKHOLM, Dec. 6, 2023 STOCKHOLM, Dec. 6, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical...

Bulletin from Extraordinary General Meeting in Medivir AB (publ)

Bulletin from Extraordinary General Meeting in Medivir AB (publ) PR Newswire STOCKHOLM, Dec. 1, 2023 STOCKHOLM, Dec. 1, 2023 /PRNewswire/ -- Today on 1 December 2023, Medivir AB (publ) (the...

Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC

Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC PR Newswire STOCKHOLM, Nov. 27, 2023 STOCKHOLM, Nov. 27...

Medivir to present at the Redeye Life Science Day

Medivir to present at the Redeye Life Science Day PR Newswire STOCKHOLM, Nov. 22, 2023 STOCKHOLM, Nov. 22, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company...

Medivir to present at the Erik Penser Bank Company Event

Medivir to present at the Erik Penser Bank Company Event PR Newswire STOCKHOLM, Nov. 21, 2023 STOCKHOLM, Nov. 21, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	41.7	41.7	41.7	4161	41.7	DE
4	41.7	41.7	41.7	1508	41.7	DE
12	41.7	41.7	41.7	503	41.7	DE
26	41.7	41.7	41.7	230	41.7	DE
52	41.7	41.7	41.7	164	41.7	DE
156	41.7	41.7	41.7	88	41.7	DE
260	41.7	41.7	41.7	277	41.7	DE

0GP7 - Frequently Asked Questions (FAQ)

What is the current Medivir Ab share price?

The current share price of Medivir Ab is SEK 41.70

How many Medivir Ab shares are in issue?

Medivir Ab has 105,371,000 shares in issue

What is the market cap of Medivir Ab?

The market capitalisation of Medivir Ab is SEK 4.39B

What is the 1 year trading range for Medivir Ab share price?

Medivir Ab has traded in the range of SEK 41.70 to SEK 41.70 during the past year

What is the PE ratio of Medivir Ab?

The price to earnings ratio of Medivir Ab is -49.19

What is the cash to sales ratio of Medivir Ab?

The cash to sales ratio of Medivir Ab is 573.59

What is the reporting currency for Medivir Ab?

Medivir Ab reports financial results in SEK

What is the latest annual turnover for Medivir Ab?

The latest annual turnover of Medivir Ab is SEK 7.66M

What is the latest annual profit for Medivir Ab?

The latest annual profit of Medivir Ab is SEK -89.32M

What is the registered address of Medivir Ab?

The registered address for Medivir Ab is LUNASTIGEN 5, 2ND FLOOR, PO BOX 1086, HUDDINGE, SE-141 22

What is the Medivir Ab website address?

The website address for Medivir Ab is www.medivir.se

Which industry sector does Medivir Ab operate in?

Medivir Ab operates in the PHARMACEUTICAL DIVERSIFIED sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TIRTiger Royalties And Investments Plc	0.15p (50.00%)	3.41M
BAYBay Capital Plc	5.50p (19.57%)	209.68k
MASTMast Energy Developments Plc	0.19p (18.75%)	20.09M
MHNMenhaden Resource Efficiency Plc	148.50p (18.33%)	1M
ZENZenith Energy Ltd.	2.50p (16.28%)	3.93M
TRYBTribe Technology Plc	0.115p (-79.09%)	24.27M
NMTNeometals Ltd	2.75p (-35.29%)	49.4k
SNGSynairgen Plc	2.46p (-34.31%)	4.31M
TM1Technology Minerals Plc	0.185p (-26.00%)	174.03M
AYMAnglesey Mining Plc	0.70p (-17.65%)	2.99M
NTVONativo Resources Plc	0.002p (5.26%)	971.94M
TRPTower Resources Plc	0.035p (9.38%)	620.03M
LLOYLloyds Banking Group Plc	54.16p (-0.26%)	341.48M
ORCPOracle Power Plc	0.0255p (-1.92%)	192.93M
TM1Technology Minerals Plc	0.185p (-26.00%)	174.03M